Health CanadaGeneral Alert
Health Canada advises Allergan of its intent to suspend its licences for Biocell...
Published: April 4, 2019Recall ID: 59319Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
Health Canada advises Allergan of its intent to suspend its licences for Biocell breast implants as a precautionary measure
Additional Source Details
| Field | Value |
|---|---|
| N I D | 59319 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/health-canada-advises-allergan-its-intent-suspend-its-licences-biocell-breast-implants |
| Issue | Product safety |
| Title | Health Canada advises Allergan of its intent to suspend its licences for Biocell breast implants as a precautionary measure |
| Archived | 0 |
| Category | Medical devices |
| Last updated | 2019-04-04 |
| Organization | Communications and Public Affairs Branch |